New approach to treat type II diabetes failing on maximal oral treatment.
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2011
At a glance
- Drugs Glimepiride (Primary) ; Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ANN
- 31 Aug 2018 Biomarkers information updated
- 08 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 08 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.